Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On May 3, 2022, Valor Latitude Acquisition Corp. (the "Company") received a written notice (the "Notice") from the Listing Qualifications Staff of the Nasdaq Stock Market ("Nasdaq") indicating that, due to Mr. Hélio Lima Magalhães ceasing to be an independent director and member of the Company's board of director committees, the Company no longer complies with Nasdaq's independent director requirement as set forth in Listing Rule 5605.

The Notice stated that, consistent with Listing Rule 5605(b)(1)(A), Nasdaq will provide the Company a cure period in order to regain compliance as follows: (i) until the earlier of the Company's next annual shareholders' meeting or February 22, 2023; or (ii) if the next annual shareholders' meeting is held before August 22, 2022, then the Company must evidence compliance no later than August 22, 2022.

The Company is working diligently to find qualified individuals to add additional independent directors or otherwise adjust the composition of its board of directors as needed prior to the expiration of the applicable cure period in order to comply with Nasdaq's independent director requirements as set forth in Listing Rule 5605.

This Current Report on Form 8-K is filed to satisfy the obligation under Nasdaq Listing Rule 5810(b) and Item 3.01(a) of Form 8-K that the Company make a public announcement disclosing the deficiency no later than four business days from the date of the Notice.

© Edgar Online, source Glimpses